openPR Logo
Press release

Global HIV Diagnosis & Treatment Market Research and Forecast 2017-2022

02-02-2018 01:46 PM CET | Health & Medicine

Press release from: Orion Market Research

Global HIV Diagnosis & Treatment Market Research and Forecast

HIV Diagnosis & Treatment Market, size, share, market intelligence, company profiles, market trends, strategy, analysis, forecast 2017-2022

HIV TREATMENT MARKET INSIGHTS:
The global Human Immunodeficiency Virus (HIV) diagnosis & treatment market is expected to grow at a CAGR of 7.6 % during 2017-2022. The HIV impact on the immune system of human body and weakens the individual defense system against any infections. It attacks & destroys a type of white blood cell, T-helper cell and replicates. Its produces have several copies of itself inside these white blood cells. Progressively the immune system becomes weak to any kind of infections. This condition and situation is known as acquired deficiency syndrome (AIDS). According to world health organization (WHO), it is a main global public health issue. In 2015, 1.2 million people died with HIV related infections across the globe and approximately 36.8 million people are currently suffering from HIV.

For More info: https://www.omrglobal.com/industry-reports/hiv-treatment-and-diagnosis-market/

As a result, the global HIV diagnosis and treatment market is rapidly growing, and continuously working on trials for the proper diagnosis followed by treatment. The market for HIV treatment market is growing at the pace, and also the increasing occurrence of HIV/AIDS infection globally boosting is the market, also government taking initiatives diagnosis and treatment and increasing in blood donations and blood transfusions and increasing awareness about HIV/AIDS. One of the major reason for the increase in the number of HIV infection across the globe, includes, changing lifestyle, injection drug usage, and lack of awareness and unprotected sex in some region. A prime factor driving the market for HIV treatment market is government and Non-governmental organizations (NGOs) efforts to initiate against HIV/AIDS.

The HIV diagnosis & treatment market was segmented majorly on the basis of type, product, treatment, and end user. On the basis of type, the market is further segmented into antibody tests, viral identification assays, cd4 testing, viral load testing, and early infant diagnostics. Antibody tests have a largest market share in the diagnosis of AID. On the basis of product, HIV diagnosis & treatment market can be segmented into assays and kits & reagents, instruments and software & service. In product segment, the product assays and kits is anticipated to lead the growth of the global HIV diagnosis & treatment market during the next few years. On the basis of treatment HIV diagnosis & treatment market can be segmented into protease inhibitors (PIS), non-nucleoside reverse transcriptase inhibitors (NNRTIS), nucleoside or nucleotide reverse transcriptase inhibitors (NRTIS), entry or fusion inhibitors, integrase inhibitors and others. In the treatment segment, the protease inhibitors (PIS) are the main treatment for the t global HIV treatment market.

GEOGRAPHICAL INSIGHTS:
North America and Europe are the leading the market of the global HIV diagnosis & treatment market having strong healthcare R&D scenario. Regional government is taking initiatives for the ongoing diagnostic efforts for development of new treatment and products. Asia Pacific is anticipated to grow at the high pace due to many issues regarding screening and testing of HIV. Furthermore, partnerships among the western market players and the governments in the region are another major aspect fueling the growth of HIV diagnosis market.

Competitive Insights:
The main players functioning in the global HIV diagnosis & treatment market include Siemens Healthcare, Abbott Laboratories, Roche molecular systems Inc., Bio-Rad laboratories, QIAGEN, Danaher Corporation, Becton, Dickinson and company, Merck KGAA, Biomerieux SA, Medmira Inc., Hologic Inc., Alere Inc., and others. In 2015, the U.S. food and drug administration (FDA) has approved the Siemens ADVIA Centaur HIV Ag/Ab combo (CHIV) assay.

MARKET SEGMENTATION:
HIV treatment market research and analysis, by type
HIV diagnosis & treatment market research and analysis, by product
HIV diagnosis & treatment market research and analysis, by treatment
HIV diagnosis & treatment market research and analysis, by user

THE REPORT COVERS:
Comprehensive research methodology of HIV diagnosis & treatment market.
This report also includes detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the HIV diagnosis & treatment market.
Insights about market determinants which are stimulating the HIV diagnosis & treatment market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

We provide detailed analysis of Healthcare IT Market which includes Market Estimation, Market Segments, regulations and policies. Moreover, the markets in emerging economies such as India, China, Japan and Korea are expected to show a double digit growth due to improved infrastructure, huge customer base and improved healthcare spending.

At OMR we provide you in-depth analysis of the Healthcare IT Market which includes Cloud healthcare, healthcare analytics, digital pathology, healthcare payer solutions, HCIT outsourcing services, clinical and non-clinical solutions. It includes tax policies, export-import policies and environment laws by top geographies. We provide detailed analysis of each segment along with market driver, restraints and opportunities. Our numbers are confirmed through extensive primary research. OMR’s Healthcare IT Market reports will provide you a great decision making tool.

CORPORATE OFFICE:

Orion Market Research Pvt Ltd
116, Shagun Arcade
Vijay Nagar Square
Indore, Madhya Pradesh – India- 452010
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404
Global: +1-646-755-7667

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global HIV Diagnosis & Treatment Market Research and Forecast 2017-2022 here

News-ID: 928482 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways